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ABSTRACT
Plasmids, conjugative transposons and phage
frequently encode anti-restriction proteins to
enhance their chances of entering a new bacterial
host that is highly likely to contain a Type I DNA
restriction and modification (RM) system. The RM
system usually destroys the invading DNA. Some
of the anti-restriction proteins are DNA mimics and
bind to the RM enzyme to prevent it binding to DNA.
In this article, we characterize ArdB anti-restriction
proteins and their close homologues, the KlcA
proteins from a range of mobile genetic elements;
including an ArdB encoded on a pathogenicity
island from uropathogenic Escherichia coli and a
KlcA from an IncP-1b plasmid, pBP136 isolated
from Bordetella pertussis. We show that all the
ArdB and KlcA act as anti-restriction proteins and
inhibit the four main families of Type I RM systems
in vivo, but fail to block the restriction endonuclease
activity of the archetypal Type I RM enzyme, EcoKI,
in vitro indicating that the action of ArdB is indirect
and very different from that of the DNA mimics.
We also present the structure determined by NMR
spectroscopy of the pBP136 KlcA protein. The
structure shows a novel protein fold and it is
clearly not a DNA structural mimic.
INTRODUCTION
DNA restriction and modiﬁcation (RM) systems are wide-
spread in bacteria and archaea, and function as defence
systems to reduce the inﬂux of foreign DNA on mobile
genetic elements via transduction, transformation and
conjugation (1–3). The RM systems can be classiﬁed
into four types, I–IV, depending upon their complexity
of structure and function (2) with the Type I RM
enzymes being the most complex exhibiting both restric-
tion endonuclease and modiﬁcation methyltransferase
activities in one large complex although a sub-
assembly can act as a monofunctional modiﬁcation
methyltransferase (4). These enzymes are composed of
three subunits encoded by the genes hsdR, hsdM and
hsdS (hsd denotes ‘host speciﬁcity of DNA’). HsdM
(50–60 kDa) and HsdS (50 kDa) subunits comprise a
methyltransferase (Mtase, M2S1), which in association
with HsdR forms an endonuclease (R2M2S1). The HsdR
(140 kDa) subunits are required for restriction, the HsdS
subunit speciﬁes the DNA target sequence and the HsdM
subunits catalyses the methylation reaction. Depending
upon the methylation state of the DNA, the RM
complex can function as either an endonuclease (REase)
or an Mtase. The REase will cleave incoming DNA that
has not been appropriately modiﬁed by the Mtase. If the
target sequence is unmodiﬁed (unmethylated) then it is
targeted for restriction. If the target sequence is
hemi-methylated, the unmethylated target strand also
becomes methylated as well. Fully methylated DNA is
immune to restriction. The Type I RM systems are
further subdivided into families, ﬁve of which are
deﬁned at present by DNA hybridization, subunit
complementation, antibody cross-reactivity and sequence
conservation.
These complex Type I systems are found in over 50% of
bacterial species (5) and this defence can be extremely
strong (6). They therefore place a considerable
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evolutionary pressure on mobile genetic elements to
evolve anti-restriction countermeasures encoded by the
foreign DNA (2,3,7). One such measure is the use of
anti-restriction proteins to modify or inactivate the RM
system. These are frequently targeted against Type I RM
systems and operate in a variety of diﬀerent manners. The
simplest anti-restriction proteins mimic the structure of
DNA and include the proteins ocr from phage T7 and
ArdA from plasmids and conjugative transposons (8,9).
The ocr protein from phage T7 (9,10) and the ArdA
proteins from conjugative plasmids and conjugative
transposons (3,8,11–15) have been the most intensively
studied of the DNA mimics. These inactivate the host’s
Type I RM enzyme by binding in the substrate (DNA)
binding groove (16,17). The structure of these proteins
shows they mimic DNA both in size and surface charge
distribution and have high aﬃnity for binding to the RM
enzyme. Another group are single-strand DNA binding
proteins and represented by the ArdC protein (7,18).
Binding to the single-stranded DNA intermediate
formed during conjugation seems to lead to anti-
restriction though why this occurs is unclear as the Type
I RM systems act on double-stranded DNA (11,18). The
ArdB proteins (7,11,18) and their close homologues the
KlcA proteins (19,20) are the subject of this study.
In annotated sequence databases, the ArdB proteins
appear to be mostly conﬁned to the proteobacteria. For
instance, Escherichia coli K12 W3110 contains two
prophages on its chromosome, CP4-6 and CP4-57,
encoding ardB homologues termed yafX and yfjX, respec-
tively (21). Comparison of the predicted products of these
two genes with sequence databases indicates that they are
highly homologous to the ArdB protein from the IncN
incompatibility group conjugative plasmid pKM101 (11).
Similarly, another putative ardB, ORF14, is encoded
by the second pathogenicity island, PAI IICFT073, from
the uropathogenic E. coli CFT073 (22,23). Putative
homologues have also been identiﬁed in Legionella
pneumophila (24) and Achromobacter denitriﬁcans (25).
The ArdB proteins are small in size with an acidic
nature, which is similar to ocr and ArdA. The anti-
restriction function for ardB from pKM101 has been
demonstrated but it was also observed that it did not
inhibit modiﬁcation (11) in contrast to the ocr and
ArdA DNA mimics. This inability to block modiﬁcation
occurred despite the presence of the short ‘anti-restriction
amino acid motif’ identiﬁed in ocr, ArdA and ArdB (7,26).
The recent atomic structure of ArdA indicates that this
motif has a structural role in maintaining the fold of
ArdA rather than a direct role in inhibiting the RM
enzyme (8). Therefore, the presence of this motif in
ArdB does not necessarily imply a functional role.
klcA is one of three genes found on the kilC operon, one
of four kil loci (20) found on IncP plasmids. Expression of
kil genes can be lethal to E. coli and is regulated by the kor
genes. korA and korC control klcA on the broad host
range plasmid RK2. klcA from RK2 showed 31%
identity and 56% similarity to ardB from pKM101.
Plasmids of the incompatibility group P are found in a
wide range of Gram-negative bacteria (27). IncP-1b
members usually carry multiple antibiotic resistance
determinants and genes for the degradation
of xenobiotic compounds (28). An exception is the
IncP-1b plasmid pA1 from Sphingomonas sp. A1 that
does not contain any of the typical accessory genes of
IncP-1bplasmids (29). Similarly, pBP136, isolated from
Bordetella pertussis in a fatal case of whooping cough
(19) was found to contain no accessory genes for antibi-
otic resistance, remnants of insertion sequences or
transposons. It contains two regions involved in plasmid
conjugation and a third region involved in plasmid repli-
cation, central control, stable inheritance and partitioning.
This region contained a klcA gene encoding a protein with
71% identity to KlcA from RK2. Sequence alignment
revealed that KlcA from pBP136 is also signiﬁcantly
related to the anti-restriction ArdB proteins (19)
showing, e.g. 30% identity and 46% similarity to the
16.5 kDa ArdB from the IncN plasmid pKM101 (11).
The signiﬁcant homology of KlcA to ArdB implied a
possible function of KlcA as an anti-restriction protein.
However, klcA from the IncP-1a plasmid RK2 showed no
anti-restriction activity against the archetypal Type I RM
system EcoKI from E. coli (20).
Here, we demonstrate that four ardB and two klcA
display an anti-restriction function in vivo against Type I
RM systems but contrary to expectations, we ﬁnd that in
vitro, the puriﬁed ArdB proteins are unable to prevent the
normal restriction endonuclease activity of the EcoKI
Type I RM enzyme indicating an anti-restriction mecha-
nism distinct from the DNA mimicry used by the ArdA
anti-restriction proteins (8,12,13). We present the
NMR-derived atomic resolution structure of the full
length, 142 amino acid, KlcA protein from plasmid
pBP136 isolated from B. pertussis and show that it has a
novel fold and clearly is not a DNA structural mimic.
METHODS
Strains, plasmids and genes
Escherichia coli JM109 was used as a general cloning
strain (Promega Madison, WI, USA). The expression
strain E. coli BL21(DE3) was purchased from Invitrogen
(Groningen, The Netherlands). The E. coli strains used for
assessing restriction activity in vivo comprise NM1261
(rm), NM1049 (restriction system Type IA), NK354
(Type IB), NK402 (Type IC), NM1009 (Type ID) and
were a kind gift of Professor Noreen E. Murray (School
of Biology, University of Edinburgh, UK). NM1041
(hsd+ clpX) was again obtained from Noreen Murray
(30). The NK and NM series were converted to DE3
lysogens as described previously (8).
Four ArdB genes were identiﬁed in the public sequence
database held by the National Center for Biotechnology
Information (Bethesda, MD, USA), Table 1. The gene
sequences were then synthesised by GeneArt
(Regensburg, Germany). The codon usage pattern was
optimized in order to maximize expression yield in
E. coli. To facilitate cloning, an NdeI restriction site
was engineered to overlap the ATG start codon of each
synthetic gene. In addition, a unique HindIII site was
also included just downstream of the stop codon.
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The synthesised genes were then ligated into pET24a
(kanamycin resistant) at the NdeI and HindIII sites of
the expression vector and the anticipated sequence was
veriﬁed by DNA sequencing on both strands. Two
further ardB genes from E. coli DH5a (yjfX and yafX),
Table 1, were PCR-ampliﬁed from genomic DNA and
ligated into pET20b (Novagen, Madison, WI, USA).
The primers used to amplify yfjX were: forward primer,
50-ACGGTGTCATATGACAACACAGACACAGT-30;
reverse primer, 50-GCTAGAATTCTTAATCAATAATG
CGCAT-30. The primers used to amplify yafX were:
forward primer 50-ACGGTGTCATATGACAACACAG
ACGCAGC-30; reverse primer, 50-GCTAGAATTCTCA
GTCGATAATACGCAG-30. The NdeI and EcoRI recog-
nition sites used in the subsequent ligation are underlined.
In both cases an ampliﬁed product of the expected size
was obtained. The PCR products were then ligated into
the NdeI and EcoRI sites of pET20b (ampicillin resistant).
The sequence of the insert was veriﬁed to ensure
no mistakes had been introduced during ampliﬁcation.
For assessing the eﬀect of expressing klcA136 in
NM1041(DE3) (hsd+ clpX) on growth in the presence
and absence of 2-AP, klcA136 was ligated into an expres-
sion vector with a carbenicillin selection marker (pET20b).
This was achieved by digesting the KlcA136 pET24a
expression construct with NdeI and HindIII and ligating
the insert into the corresponding sites of pET20b to
produce pET20b-klcA136.
The extinction coeﬃcients of the proteins were
calculated using the method of Gill and von Hippel (31),
Table 1. All concentrations quoted for the proteins are
based on the concentrations of monomers. The
monomer molecular weights of the proteins are shown
in Table 1 and include the N-terminal methionine.
Expression and puriﬁcation of proteins
Escherichia coli BL21(DE3) cells were transformed with
the recombinant plasmid and transformants selected
using LB agar supplemented with 25 mg/ml kanamycin
or 100 mg/ml carbenicillin. A single colony was picked
and grown in LB medium plus 25 mg/ml kanamycin or
100 mg/ml carbenicillin at 37C to an optical density at
600 nm (OD600) of 0.5. Heterologous gene expression
was induced by the addition of IPTG to 1mM and the
growth continued for a further 3 h at the temperature
given in Table 1 before harvesting. For four of the
chosen genes, a prominent protein band corresponding
to the predicted protein mass was visible on SDS–
polyacrylamide gels of induced cells of BL21(DE3) con-
taining the recombinant plasmid that was not visible in
the negative control of the vector alone in BL21(DE3).
The A. denitriﬁcans klcA and L. pneumophila ardB could
not be expressed at levels suﬃcient for puriﬁcation. For
protein production, a single colony of was used to inocu-
late 100ml of LB medium supplemented with 25 mg/ml
kanamycin or 100 mg/ml carbenicillin. The starter culture
was grown to an OD600 of 0.5–0.8 at 37
C and used to
inoculate 10L of LB containing 25 mg/ml kanamycin or
100 mg/ml carbenicillin and the cells grown at 37C to an
OD600 of 0.5. Heterologous gene expression was induced
as described above. Typically 50 g of cells were obtained
from 10 l of culture. Cells were harvested by centrifugation
(6000g, 4C, 15min) and the cell pellet was stored at
20C until required.
Approximately 20 g of cell pellet was defrosted on ice
for 30min and resuspended in 200ml buﬀer A (20mM
Tris–HCl pH 8.0, 7mM 2-mercaptoethanol). A cocktail
of protease inhibitors (Complete Protease Inhibitor
Cocktail Tablet; Roche) was added to the cell suspension
(1 tablet per 50ml solution). The cells were disrupted by
sonication on ice using a Soniprep 150 sonicator (Sanyo,
Tokyo, Japan) ﬁtted with a 9mm diameter probe
(5 1min bursts with 15 s interval between each burst).
The cell lysate was centrifuged at 20 000g for 1 h at 4C
and the supernatant was ﬁltered through a 0.45 mm ﬁlter
unit (Sartorius AG, Goettingen, Germany). The clariﬁed
extract was then loaded onto a 30 cm 1 cm diameter
DEAE anion exchange column equilibrated with buﬀer
A, at a ﬂow rate of 60ml/h. The column was washed
with 3 column volumes of buﬀer A to remove unbound
material. Bound proteins were then eluted using a 500ml
gradient of 0–0.7M NaCl in buﬀer A at a ﬂow rate of
20ml/h. Fractions that gave a UV absorbance were
subsequently analysed by SDS–PAGE and those contain-
ing ArdB were pooled and concentrated using a spin
concentrator with a 5 kDa MWCO (VivaScience AG,
Hannover, Germany) to a ﬁnal volume of 5ml. The
sample was then loaded on a Superdex-200 column (GE
Healthcare, Uppsala, Sweden), equilibrated with buﬀer
A+0.2M NaCl, and the protein was eluted at a ﬂow
rate of 10ml/h. The fractions were subsequently
Table 1. The source of the ardB and klcA genes investigated
Identiﬁer in
NCBI protein
database
Gene Protein
annotation
Our
name
Organism Amino
acid
length
Molecular
weight
including
N-terminal
methionine
Molar
extinction
coeﬃcient
M1 cm1
Predicted
isoelectric
point
Optimal
protein
expression
temperature
(

C)
Reference
NP_752219 ORF14 ArdB ArdBCFT E. coli CFT073 157 17 832.1 34 410 4.83 37 (23)
ACB01415 yafX ArdB ArdBYAF E. coli K12/CP4-6 prophage 152 17 419.5 37 410 4.76 37 (21)
AAC75691 yfjX ArdB ArdBYFJ E. coli K12/CP4-57 prophage 152 17 303.3 37 410 4.64 37 (21)
YP_122202 plpp0047 ArdB ArdBLPP L. pneumophila str. Paris 134 15 409.5 26 740 5.05 25 (24)
BAF33451 KlcA KlcA KlcA136 B. pertussis BP136 142 15 659.6 22 900 4.84 30 (19)
NP_990889 pEST4011_14 KlcA KlcAADE A. denitriﬁcans 144 16 026.8 21 620 4.74 30 (25)
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analysed by SDS–PAGE and those containing ArdB were
pooled and concentrated. Puriﬁed ArdB/KlcA was
stored at 20C in buﬀer A supplemented with glycerol
to 50% (v/v).
Analysis of proteins
The methods employed for assaying ardB activity in vivo
used the eﬃciency of plating (eop) of phage lambda
(virulent), v, on the various strains of E. coli as described
previously in detail (8,13). The NM and NK E. coli strains
were transformed with the derivatives of pET24a or
pET20b described above but protein overexpression was
not induced. Instead, we relied upon the small amount of
leaky expression to produce the anti-restriction proteins in
suﬃcient quantity to demonstrate anti-restriction in vivo.
All assays were performed in triplicate and at least
50 phage plaques per plate were counted. The standard
deviation on the anti-restriction and anti-modiﬁcation
values is±25%.
To assess the possible role of the ClpXP in the
anti-restriction behaviour of ArdB and KlcA, the ability
of E. coli NM1041 (hsd+ clpX) transformed with
plasmids expressing ardB or klcA to survive on an agar
plate containing 2-aminopurine (2-AP) was assessed (32).
The strain will not grow in the presence of 2-AP unless the
EcoKI RM system is inactivated by the production of
active ArdB or KlcA. A single colony from an agar/
carbenicillin plate of E. coli NM1041 transformed with
either pET20b or pET20b-klcA136 was streaked on an
agar plate with or without 2-AP and incubated overnight
at 37C. This was repeated in triplicate with diﬀerent
colonies.
Fourier transform ion cyclotron mass spectrometry
(33), isothermal titration calorimetry (10,13,33), size
exclusion chromatography (34) and assays of EcoKI
endonuclease activity (8,13,34) were performed as
described previously. To investigate whether ArdB or
KlcA interfered with the assembly of the EcoKI
nuclease, 42 nM EcoKI Mtase and 100 nM HsdR
proteins (34) were incubated separately with a 20-fold
excess of ArdB or KlcA in the nuclease reaction buﬀer
for 2min at 37C. Equal volumes of these two samples
were then mixed and pBRsk1 DNA added to 3 nM.
After incubation of this reaction mix for 8min at 37C,
the reaction was stopped as above.
NMR spectroscopy and structure calculations
The KlcA protein from B. pertussis was uniformly labelled
with 15N and 13C by growing the recombinant strain in
M9-minimal medium containing 15NH4SO4 and
13C-D-
glucose as the sole nitrogen and carbon sources, respec-
tively. The labelled protein was puriﬁed as described
above. Samples for NMR measurements contained
0.7mM KlcA, 90% H2O/10% D2O and 0.05% NaN3 in
20mM deuterated sodium acetate buﬀer (pH 6.0).
All NMR experiments were carried out at 298K unless
stated otherwise on a Bruker AVANCE 800MHz with a
5-mm triple resonance cryoprobe. NMR experiments for
1H, 15N and 13C backbone and side-chain resonance
assignments included: two-dimensional (2D) 1H-1H
TOCSY, 1H-1H NOESY, 1H-15N HSQC, 1H-13C HSQC,
(HB)CB(CGCD)HD/(HB)CB(CGCDCE)HE,
three-dimensional (3D) HNCO, HN(CA)CO, CBCANH,
CBCA(CO)NH, HBHA(CO)NH, HBHANH,
(H)CCH-TOCSY, H(CCO)NH, C(CO)NH (35). 3D
15N- and 13C-edited NOESY-HSQC spectra were
acquired to obtain distance constraints (36,37). Aromatic
1Hd and 1He frequencies were obtained from
(HB)CB(CGCD)HD/ (HB)CB(CGCDCE)HE spectra
(38) where the aromatic 1H frequencies are correlated
with the assigned 13Cb frequencies of the aromatic residue.
NMR data were processed using the Azara suite of
programs (Wayne Boucher, Department of
Biochemistry, University of Cambridge, UK,
http://www.ccpn.ac.uk/azara/) and analysed using
Ccpnmr Analysis (39). NOE assignments were generated
during the initial rounds of structure analysis using
CANDID (40) in CYANA 2.1 (41). Dihedral constraints
were generated using TALOS (42). The NOE assignments
obtained by CANDID were checked manually and from
the 100 structures calculated, 20 structures with lowest
target function were selected for further analysis. The
structures were further reﬁned with the incorporation of
residual dipolar couplings (RDCs) using CNS (43).
PROCHECK-NMR (44) and WHATIF (45) were used
to analyse the quality of the structures. MOLMOL (46)
and PYMOL (http://www.pymol.org) were used for
visualisation.
A 200 mM 15N-labelled KlcA sample in 20mM
deuterated sodium acetate, 0.05% NaN3, pH 6.0 in 90%
H2O/10% D2O aligned with 6.25mg/ml of Pf1 ﬁlamen-
tous phage (Pf1 protease and RNase free, Profos) was
used to measure RDCs. Magnetic alignment was moni-
tored by 1D 2H NMR spectra as a function of phage
concentration. A 7Hz residual quadrapolar splitting of
the deuterium signal was achieved with 6.25mg/ml
phage. 1H-15N splittings were measured under isotropic
and partially aligned conditions using 2D IPAP 1H-15N
HSQC experiments (47). Analysis and back calculation of
the RDCs were performed with REDCAT (48).
Relaxation experiments were performed on a 600MHz
Bruker Avance spectrometer at 25C with 200mM 15N
labelled KlcA. For the longitudinal (T1) and transverse
(T2) relaxation data for the backbone
15N nuclei of
KlcA, water was kept along the z-axis during the entire
pulse sequence (49) and extra delays were used in the T1
experiment to eliminate diﬀerential heating arising from
the variations of the relaxation delay (50). Eight
interleaved spectra were recorded for each relaxation
delay T1 (51 twice, 401, 601, 801, 901, 1001 and
1201ms) and T2 (16 twice, 48, 64, 80, 96, 112 and
144ms). T1 and T2 cross-peak intensities were measured
from peak heights and ﬁt to an exponential decay function
I(t)= I(0)eRt where I(0) and I(t) are the cross-peak inten-
sity at time 0 and time t, where time is the relaxation delay
and R (1/T) is the relaxation rate (39). For the 2D 1H-15N
heteronuclear NOE experiment (49) a 3 s pre-saturation
period and a 2 s relaxation delay was used; the control
experiment had an equivalent 5 s delay. Spectra from the
heteronuclear NOE experiment were extended by linear
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prediction and zero ﬁlling prior to apodisation with a 5%
shifted mixed Gaussian/exponential function. NOE peak
heights were taken from the Gaussian ﬁts of the
frequency-domain data. The NOE was calculated as
NOE= Ion/Ioﬀ where Ion and Ioﬀ are the peak heights
with and without 1H pre-saturation, respectively. T1, T2
and NOE data were ﬁtted using ‘Quadric_diﬀusion’, (AG
Palmer, Columbia University, NY, USA, http://biochem
istry.hs.columbia.edu/labs/palmer/software/quadric.html)
to obtain the rotational diﬀusion tensor. Model-free
analysis of the relaxation data was performed using
Tensor2 (51). For this analysis a subset of relaxation
data was selected using criteria deﬁned by Tjandra et al.
(52). The relative moments of inertia were calculated with
‘pdbinertia’ (http://biochemistry.hs.columbia.edu/labs/
palmer/software/pdbinertia.html) and the average
rotational correlation time (tc) calculated with
r2r1_tm (http://biochemistry.hs.columbia.edu/labs/
palmer/software/r2r1_tm.html).
The complete set of coordinates for the structure has
been deposited at the Protein Data Bank (PDB) (53)
with accession code 2 kmg and in the Biological
magnetic resonance bank with code 16428.
Bioinformatics analysis of sequence and structure
Secondary structure was identiﬁed using STRIDE (54).
Fold topology analysis was conducted using HERA (55)
under PROMOTIF v2.0 (56) and schematically redrawn
using TopDraw (57). The B. pertussis KlcA sequence was
subjected to a BLAST search (58) against the PDB and to
fold recognition server PHYRE (59) to check if there
was any clear or remote homology to an existing structure
or fold at the sequence level. Additionally, the
3D-coordinates of the KlcA structure were compared
against 3D-fold and structure libraries using DALI (60)
and SSM (61).
Sequences related to B. pertussis KlcA (UniProt
Accession no: Q08L07) were obtained using a BLASTP
search (58) against the UniProt sequence database (62),
via the NPS@ server (63). A total of 182 sequences with
an E-value of less than 106 were obtained and this list
was made non-redundant initially by removing 62 identi-
cal sequences. The remaining 120 KlcA-like sequences
were retrieved and a multiple sequence alignment was
generated using the program PROMALS3D (64). This
set of sequences was rendered further non-redundant by
removing all 90% pairwise identical sequences in the
alignment using the Expasy server (http://www.expasy
.ch/tools/redundancy/). A total of 44 non-redundant
divergent sequences were thus obtained. Upon analysis,
one sequence that lacked the C-terminal helix 5 was dis-
carded and three other sequences, which possessed
N-terminal extensions, were trimmed. The remaining
43-aligned sequences were used as input for Consurf (65)
(http://consurf.tau.ac.il/) to map sequence conservation
on the surface of the protein. The electrostatic surface
potential representation was calculated using GRASP
(66). The lipophilic surface rendition was generated
using MOLCAD (67) under SYBYL (Tripos Associates,
St Louis, MO, USA). Solvent-accessibility calculations
were performed using GETAREA (68).
RESULTS
The ArdB proteins from the E. coli pathogenicity island,
the CP4-6 prophage, the CP4-57 prophage and
L. pneumophila will be referred to as ArdBCFT,
ArdBYAF, ArdBYFJ and ArdBLPP, respectively. The
KlcA proteins from B. pertussis and A. denitriﬁcans will
be referred to as KlcA136 and KlcAADE, respectively. The
names ArdB and KlcA without a subscript are to be
understood as referring to all of the ArdB or KlcA
studied.
Overexpression of klcA is not lethal to E. coli
It has been shown that unregulated expression of the kil
genes leads to killing of the host cells. The cells become
elongated with distorted outer membranes and
macromolecular synthesis ceases (69). Previous studies of
the kilC operon in plasmid RK2 showed that klcA was
responsible for the lethality of E. coli host cells in the
absence of korA and korC (20). However, we were able
to overexpress the klcA136 gene in a pET vector in the
absence of kor determinants with no apparent harmful
eﬀects. Furthermore, in vivo anti-restriction experiments
performed on the klcA from RK2 failed to identify any
signs of anti-restriction function (20), whereas the klcA136
and klcAADE showed eﬃcient anti-restriction activity
against all four families of Type I restriction systems as
described below.
In vivo activity of ardB and klcA genes against the four
families of Type I RM systems
The activity of anti-restriction genes can be tested by
determining how many phages successfully infect a bacte-
rial lawn in the presence or absence of host RM systems
when the bacterium also contains a plasmid encoding the
anti-restriction protein. All of the ardB and klcA genes
except ardBLPP showed signiﬁcant levels of anti-restriction
(>10-fold enhancement in the number of phage infec-
tions) despite their low levels of expression in the
absence of induction, Table 2. The poor activity of the
ardBLPP and klcAADE genes were most likely due to
poor expression as neither could be observed on SDS–
PAGE. The eﬀectiveness of the other proteins in inhibiting
restriction matched levels observed for the ocr (9,10,15,70)
and ArdA proteins (8,12,13) in vivo under similar
conditions.
However, in contrast to ocr and ArdA,
anti-modiﬁcation by ArdB was generally very weak
(<3-fold and negligible given the limitations of the
assay), Table 2. In other words, the phages that escaped
restriction were easily modiﬁed by the methylation activity
of the RM system and ArdB had little if any inhibitory
eﬀect on methylation. In three cases, some inhibition of
methylation was observed; ArdBCFT and ArdBYFJ slightly
inhibited methylation by the Type ID RM system and
ArdBYAF slightly inhibited methylation by the Type IC
RM system. These results show a clear diﬀerence
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between the activities of ArdB and KlcA compared to the
DNA mimics, ocr and ArdA, suggesting that they use dif-
ferent mechanisms for interfering with the Type I RM
systems.
KlcA136 anti-restriction function does not involve the
ClpXP protease
It has been shown that ClpXP-dependent regulation of the
EcoKI endonuclease activity enables bacteria that acquire
unmodiﬁed chromosomal target sequences to survive.
When cells are under stress after prolonged exposure to
treatments that damage DNA, such as exposure to 2-AP,
the ClpXP-dependent pathway operates to prevent EcoKI
from cleaving the chromosome (71). The restriction
subunit of the nuclease (HsdR) is degraded in the
presence of ClpXP (71). As described later, we did not
observe any direct interaction of KlcA136 with the
EcoKI in vitro; therefore we tested the hypothesis that
the anti-restriction activity of KlcA136 was dependent on
the ClpXP pathway. A clpXmutant, NM1041(DE3), was
plated in the presence and absence of 80 mg/ml 2-AP,
Figure 1. The clpX mutant was also transformed with
the plasmid, pET20b-klcA136, expressing klcA136. As
expected, the clpX strain with no anti-restriction deter-
minant present, grew well in the absence of 2-AP, but no
growth was observed in the presence of 2-AP. In contrast,
the clpX strain carrying klcA136 grew equally well in both
the presence and absence of 2-AP. This ﬁnding indicates
that KlcA136 is able to block EcoKI restriction without
involving the ClpXP protease. We assume that this
result holds for ArdB and KlcA in general.
Solution state behaviour of ArdB and KlcA proteins
During puriﬁcation it was noted that ArdBYAF and
ArdBCFT behaved anomalously on a large volume
(60 cm 1.6 cm) Superdex 200 size-exclusion chromatog-
raphy column despite showing only a single homogeneous
species of the correct molecular weight on SDS–PAGE
(data not shown) and mass spectrometry, Supplementary
Table S1. Analysis with a small volume analytical column
(25 cm 0.46 cm) revealed two peaks corresponding to a
dimer and a monomer for ArdBYAF while ArdBCFT
showed two peaks on the large volume column and a
broad peak with shoulders on the small volume column,
Figure 2. ArdBYFJ and KlcA136 showed only a single
monomer peak. These results indicate that there was
Table 2. Eﬀect of expression of six diﬀerent ardB and klcA on the RM of bacteriophage v by four diﬀerent Type I RM systems, each
representing one of the four families (IA–ID) of Type I RM systems
Gene Chromosomal restriction system in host E. coli
NM1049 Type IA EcoKI NK354 Type IB EcoAI NK402 Type IC EcoR124I NM1009 Type ID StySBLI
Anti-restriction Anti-modiﬁcation Anti-restriction Anti-modiﬁcation Anti-restriction Anti-modiﬁcation Anti-restriction Anti-modiﬁcation
ardBCFT 710 2.0 54 1.8 199 1.3 1174 6.0
ardBYAF 9250 1.4 27 1.6 7510 10.6 1080 1.5
ardBYFJ 6160 1.2 10 1.1 251 1.0 1650 18.6
klcAADE 1140 1.6 14 1.2 13 1.9 37 1.2
klcA136 2430 1.4 76 1.1 628 3.1 969 1.4
ardBLPP 270 1.1 17 1.1 1.9 1.4 132 1.4
Vector alone 1 1 1 2 1 2 1 1
The host E. coli contained a chromosomal copy of the RM system and an uninduced expression plasmid expressing ardB or klcA at low level. An
anti-restriction or anti-modiﬁcation value >2 was taken to indicate anti-restriction activity in vivo. Errors in the anti-restriction and anti-modiﬁcation
values are±25%.
Figure 2. An overlay of elution proﬁles for diﬀerent proteins from a
small volume (25 cm 0.46 cm diameter) size exclusion chromatography
column showing the variable quaternary structure of the four diﬀerent
proteins in 20mM Tris, 20mM MES, 0.2M NaCl, 0.1mM EDTA,
7mM b-mercaptoethanol, pH 6.5: ArdBCFT (black, 4mM)), ArdBYAF
(blue, 3 mM), ArdBYFJ (red, 5 mM) and KlcA136 (green, 4mM). The
proteins were detected using tryptophan ﬂuorescence emission and
are arbitrarily scaled vertically.
Figure 1. The eﬀect of expressing KlcA136 in a 2-AP sensitive strain of
E. coli. A single colony of the ClpX strain NM1041(DE3) harbouring
either the KlcA expression construct (pET20b-klcA136) or the corre-
sponding vector alone (pET20b) was picked with a loop and spread
onto an LB agar plate supplemented with 100mg/ml carbenicillin, 25 mg/
ml kanamycin in the absence (A) or presence (B) of 2-AP (80 mg/ml).
The plates were then incubated at 37C for 14 h.
1728 Nucleic Acids Research, 2010, Vol. 38, No. 5
 at Edinburgh U
niversity on June 7, 2013
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
genuine heterogeneity in the quaternary structure for two
of the four proteins and the dependence on column
volume for the ArdBCFT protein further suggested that
the apparent switching between the monomer and dimer
forms was occurring on the minute timescale of the chro-
matography process.
In vitro activity of ArdB and KlcA136 proteins against
the EcoKI Type IA restriction endonuclease
A circular plasmid containing a single copy of the target
sequence for the EcoKI type I RM enzyme is eﬃciently
cleaved by stoichiometric amounts of EcoKI in the
presence of the essential cofactors SAM, ATP and
Mg2+ resulting in a linearised plasmid (34).
Stoichiometric amounts of the ocr and ArdA anti-
restriction proteins inhibit this activity by binding
strongly to and blocking the DNA binding site on
EcoKI (9,12,13). Figure 3 shows that addition of a
20-fold excess of ocr or ArdA, expected to ensure
complete inhibition, did indeed prevent any nuclease
activity of the EcoKI restriction enzyme. Addition of the
same concentration and degree of excess of any of the
examined ArdB or KlcA136 proteins to the endonuclease
reaction showed no observable inhibition of the
nuclease activity of EcoKI. Thus the anti-restriction
activity clearly observed in vivo was not due to an
anti-nuclease activity in contrast to what one might
expect from the results of the anti-restriction assay.
Hence, none of the ArdB or KlcA136 tested appeared
able to act as an inhibitor of the Type IA RM enzyme
EcoKI in DNA cleavage. The order of addition of the
reactants can be important for analysing Type I
endonuclease activity. For instance ocr is unable to
inhibit EcoKI if it is added after the DNA and ATP
(72) so for this reason we added the DNA last to the
mixture containing EcoKI, cofactors and anti-restriction
protein to avoid this problem. Even with this precaution,
ArdB and KlcA136 were unable to inﬂuence the
endonuclease activity of EcoKI.
KlcA136 does not bind to EcoKI Mtase
Biophysical characterization using ITC and ﬂuorescence
spectroscopy performed on two other anti-restriction
proteins, ocr and ArdA, have shown a strong interaction
of the Mtase part of EcoKI with these proteins (13,16).
However, ITC experiments performed at 10 and 25C
showed no apparent binding of KlcA136 to Mtase,
Figure 4. This result agrees with the in vivo modiﬁcation
assays where inhibition of phage DNA modiﬁcation was
not observed. Detecting the binding to the EcoKI nuclease
was not feasible using ITC due to limited amounts of the
nuclease. However, given the result of the nuclease inhibi-
tion assay, no interaction is expected with the surface of
the nuclease.
Do KlcA and ArdB interfere with assembly of EcoKI?
Since the KlcA and ArdB proteins appear unable to
interact neither with the complete EcoKI RM enzyme
nor with the core Mtase in vitro, we also examined
whether they could interact with the surface of the
HsdR restriction subunit of EcoKI that becomes buried
on binding to the Mtase. This would interfere with the
assembly of the complete RM enzyme as originally
proposed by Belogurov and Delver (26). Addition of
ArdB or KlcA prior to assembling the Mtase and HsdR
into an intact EcoKI endonuclease failed to inhibit the
endonuclease activity when DNA was subsequently
added to the mixture, Figure 5. This strongly suggests
that ArdB and KlcA do not interact with HsdR to inter-
fere with assembly of EcoKI.
Figure 3. Nuclease assay to test for inhibition of EcoKI by ArdB
proteins. Lane 1, undigested DNA; lane 2, EcoKI digested DNA;
lane 3, plus ocr; lane 4, plus Orf18 ArdA; lane 5, plus ArdBYAF;
lane 6, plus ArdBYFJ; lane 7, plus KlcA136; lane 8, plus ArdBCFT;
lane M, DNA ladder with sizes in kb. Plasmid DNA used was
non-methylated pBRsk1. Ratio of the anti-restriction proteins
(monomers) to EcoKI was 20:1. In each case the reaction mixture
minus DNA was made up and incubated for 2min at room tempera-
ture. The reaction was then initiated by adding DNA. Digestion was
carried out for 8min at 37C before quenching at 68C for 10min. CC,
closed circular plasmid; L, linear plasmid; OC, open circular plasmid.
Figure 4. Raw ITC data showing heat changes for the interaction of
KlcA136 with the EcoKI Mtase compared with data for the interaction
of ArdA with the Mtase as previously published (13). The traces show
from top to bottom: Mtase being titrated with ArdA at 25C, buﬀer
being titrated with Mtase at 25C, Mtase being titrated with KlcA136 at
25C and Mtase being titrated with KlcA136 at 10C. It is clear that
there is no interaction between the Mtase and KlcA136.
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1H, 15N and 13C chemical shift assignments and structure
calculations for KlcA136
The recorded 1H-15N HSQC spectrum, Figure 6, was con-
sistent with that of a folded protein exhibiting well
dispersed signals and very little spectral overlap.
Backbone and side-chain resonances of KlcA136 were
assigned based on 2D and 3D triple-resonance experi-
ments. Peaks in the 3D 13C and 15N edited NOESY
spectra were picked and the NOE cross-peak assignments
were obtained from the automated iterative assignment
program CANDID that works in conjunction with 3D
structure calculations in the program CYANA 2.1.
Using NOE restraints, TALOS dihedral restraints and
1H-15N RDCs (Supplementary Figure S1), the lowest
energy ensemble of 20 structures of KlcA136 were
calculated (Supplementary Figure S2). The calculations
converged well, yielding root mean square deviations of
0.63 and 0.65 for backbone and all heavy atoms in
structured regions (residues 7–142). Only a subset of
RDCs, as speciﬁed in the ‘Methods’ section for the calcu-
lation of the rotational diﬀusion tensor, was used in the
structure calculations. The structures were validated using
PROCHECK and WHATIF. In the Ramachandran plot,
98.5% of residues appeared in the most favourable and
additionally allowed regions. WHATIF packing analysis
yielded an average quality control z-score of 1.432 sug-
gesting a good quality NMR structure.
The structure of KlcA136 reveals a rigid globular protein
with a novel fold
The KlcA136 protein structure is made up of a single
domain (73) containing ﬁve a-helices (labelled 1–5), a
single 310-helix and ﬁve b-strands (labelled A–E) and
belongs to the mixed a/b class of proteins, Figure 7. The
ﬁve b-strands form two separate beta-sheets, the ﬁrst
composed of anti-parallel b-strands A, B and C and the
other made up of anti-parallel b-strands D and E.
b-Strand A usually occurs as an isolated b-bridge from
the ensemble consensus. The two b-sheets closely ﬂank
the C-terminal three a-helices (3–5) on either side. These
three helices appear to run in an almost anti-parallel
fashion to their helical axes in a classical knobs-in-holes
arrangement of a three-helical bundle. Helix 3 is the
longest of the helices located at the centre of the fold
Figure 6. 2D 1H-15N HSQC spectrum of KlcA136 at 800MHz.
Figure 5. The eﬀect of adding ArdB or KlcA during the assembly of
the EcoKI RM enzyme. Where relevant, Mtase and the R subunit were
preincubated at 25C in the presence of a 20 excess of ArdB or KlcA
protein for 5min prior to mixing and addition of DNA. Reactions
were performed at 37C for 8min. Lane 1, uncut pBRsk1 (3 nM); lane
2, pBRsk1 (3 nM) digested with EcoKI (30 nM); lane 3, pBRsk1
digested with reconstituted nuclease (equivalent to 30 nM EcoKI);
lane 4, nuclease reconstituted in the presence of ArdBYAF (20-fold
excess over nuclease); lane 5, 20-fold excess ArdBYFJ; lane 6, 20-fold
excess KlcA136; lane 7, pBRsk1 in the presence of R subunit only; lane
8, pBRsk1 in the presence of Mtase only. M, 1 kbp size marker.
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and contains several hydrophobic amino acids at its
N-terminus that are deeply buried. A stereo view of the
ensemble of the 20 lowest energy structures of KlcA136 is
shown in Supplementary Figure S2.
Querying 3D-fold libraries and the PDB with the
NMR-determined KlcA136 3D-structure demonstrated
that its fold is novel, based upon its overall spatial
arrangement and connectivity of secondary structure
elements. For example, the strongest structural similarity
found (z-score 5.1) using a DALI search of the PDB is to a
discontinuous C-terminal portion of the 257-residue chain
from G1/S-speciﬁc cyclin-D1 (PDB ID: 2W9Z), which is
a purely a-helical protein. Although the z-score indicates
structural similarity, the structurally aligned portions
require a large 37-residue insertion between helices 2 and
3 (with respect to KlcA136) that encompass b-strands B–E,
which are absent in the cyclin structure. Further conﬁrma-
tion of the novelty of fold was obtained using SSM. These
results are consistent with the lack of sequence identity/
signiﬁcance scores for the B. pertussis KlcA sequence
against PDB sequences using a BLAST search, or
remote similarity to any existing folds, when undertaking
fold recognition.
In the 1H-15N spectrum of KlcA136, two weak peaks
were observed at 15N chemical shifts of 69 and 72 ppm.
A F1
1H-coupled 1H-15N HSQC showed that these signals
belong to NH2 moieties. The
15N chemical shifts are con-
sistent with values reported for the guanidinium moiety of
arginine from BioMagResBank (74). These NH2 groups
would normally undergo chemical exchange with water
and thus not be observed. The fact that they are present
in the spectrum indicates reduced chemical exchange and
suggests that these are involved in H-bonded salt bridges.
Examination of the 3D structure of the protein, indicates
that the Ng2 of R73 (one residue before strand D) and Oe2
of E86 (strand E) are separated by 2.97 A˚, while this
distance is 4.47 A˚ for R48 (loop) and E75 (strand D).
The former pair meets the criterion (3.5 A˚) for a
H-bonded salt bridge interaction (75). Based on this
analysis the 15N peaks with chemical shifts of 69 and
72 ppm were tentatively assigned to NH2 moieties of
R48 and R73. Our relaxation data, described below,
indicate that the D and E strands are the most ﬂexible
on the fast time scale, so a H-bonded salt bridge could
stabilise these relatively short b-strands. The second inter-
action could potentially maintain the relative orientation
between the helix 2 and strands D and E, which connect to
the rest of the protein via loops.
The measured 15N longitudinal T1 and transverse T2
relaxation times and steady state 1H-15N NOEs were
measured (Supplementary Figure S3). Due to spectral
overlap, only 113 of the 137 non-proline residues of the
protein could be used for the calculation of the relaxation
parameters. The residues with higher amplitude of internal
motions have simultaneously higher values of T1 and T2.
In contrast, amide groups with the simultaneously lowest
values of T1 and T2 values belong to the residues with the
most restricted local mobility. Heteronuclear NOE values
< 0.68 were used to identify residues of the protein that
are dynamic on the ps–ns timescale. As the majority of
heteronuclear NOEs are> 0.68, the backbone exhibits
limited motions on this timescale (76). The only exceptions
were residues 3–6 that exhibited negative NOE values
indicating a ﬂexible N-terminus.
The presence of internal motion and chemical exchange
can lead to distortions of the T1/T2 ratio, and therefore the
collection of residues used to determine the diﬀusion
properties of the entire molecule excluded mobile
Figure 7. KlcA136 secondary and tertiary structure. Colour code: alpha-helices, red; beta-strands, yellow and 310 helix, purple. (A) Secondary
structure elements identiﬁed by STRIDE for the ensemble consensus shown as a topology fold schematic (55–57). (B) A cartoon representation
of the closest-to-mean 3D structure in the ensemble. Note: loops are rendered smooth for clarity.
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residues or those exhibiting slow exchange broadening. A
subset of 97 residues was used in the determination of the
diﬀusion tensor. In this subset the average values of T1
and T2 were 737 and 86ms, respectively. The relative
moments of inertia values were found to be Iz: 1.00, Iy:
0.9858 and Ix: 0.8629. Iy and Ix are very close to 1.00,
implying that the protein does not deviate signiﬁcantly
from a sphere, having slightly oblate shape. Given the
nearly spherical shape, an isotropic diﬀusion tensor with
a Diso=1.8 107 s1 was calculated and the average
rotational correlation time (tc) was found to be
8.83 ns±0.01, a value expected for a protein of this size.
In order to extract microscopic parameters of motion
from the relaxation data a model-free approach was used,
which assumes the overall and internal motions of the
molecule are independent. Based on the above analysis
of the relaxation data, an isotropic model was selected.
Relaxation data for most residues (73%) were adequately
described by the generalized order parameter S2 suggest-
ing a rigid molecule overall. The order parameter is a
measure of the degree of spatial motion of the N–H
bond where a value of zero means that the bond vector
has unrestricted motion while one implies a completely
rigid bond. An additional parameter (Rex) was required
to ﬁt 17 residues, with residues A14, A16, A91, E107, I108,
L117 and Y121 showing signiﬁcant Rex values (>2Hz),
suggesting that these N–H sites experience multiple envi-
ronments interconverting on the micro- to millisecond
time scale. Eleven residues (E4, M31, V38, W41, E47,
Y56, F64, F99, Q103, F123 and A128) did not ﬁt the
model. The order parameter S2 as a function of the
residue number is shown in Supplementary Figure S3.
The distribution of S2 values visualized on the structure
shows that the mobility on the nanosecond time scale is
slightly restricted in secondary structure elements
compared to loops (Supplementary Figure S4). The
largest mobility indicated by the smallest S2 values was
observed with residues at the N-terminus and with
residues between the end of strand C and the start of
helix 3.
The surface of KlcA136 reveals charged and hydrophobic
patches but little sequence conservation for residues in
these patches
An electrostatic surface representation generated by
GRASP shows that the surface of KlcA136 is
predominantly negatively charged, consistent with its the-
oretical pI (4.76), Figure 8. The negatively charged
side-chain residues on the KlcA136 surface reveals two
distinct clusters (i) an ‘Aspartate cluster’ made up of ﬁve
linearly arranged residues i.e. D61 (in the loop between
b-strands B and C), D110, D112, D115, D119 (in the loop
between a-helix 3 and 4 and on a-helix 4) and (ii) a
‘Glutamate cluster’ that contains amino acid residues
E47 (in the loop between a-helix 2 and b-strand B), E75
and E77 (on b-strand D), E86 (on b-strand E) and E133
(on a-helix 5). In addition to the ﬁve residues present in
the ‘Glutamate cluster’ are residues E15, D69 and D90,
which are also located nearby in 3D space. A striking
linear arrangement of positive charge involving arginine
side-chains is also evident, predominantly on the opposite
side of the KlcA136 protein surface with respect to its neg-
atively charged clusters. This ‘Arginine cluster’ contains
seven residues: R29, R33, R43, R44 on a-helix 2, R48 in
the loop between a-helix 2 and b-strand B, R84 on
b-strand E and R120 on a-helix 4. Even though three
distinct regions of charge are apparent from the
electrostatic surface representations, only a handful of
the charged residues are conserved in the 43
non-redundant sequences identiﬁed (Supplementary
Figure S5). These include R18, E35, D61, D90, R125,
E133 and D142.
Figure 8. Electrostatic surface representation of the KlcA136 protein. Two views rotated by 180
 about the y-axis of a GRASP electrostatic surface
representation of the KlcA136 protein. The molecule appears to expose many charged residues, labelled. Negative charge is coloured red and positive
charge coloured blue, ranging from 10 kBT to +10 kBT (kB: Boltzmann constant; T: temperature in Kelvin).
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Additionally, the lipophilic surface rendition generated
by MOLCAD reveals two regions of spatially contiguous
hydrophobic side-chains on one face of the molecule,
Figure 9 (left-hand panel) and another more prominent
hydrophobic region on the opposite face of the protein,
Figure 9 (right-hand panel). Among these, F21, L22, W54,
F83, L87, A128 and I141 are largely conserved. Some of
the aromatic side-chains are involved in aromatic–
aromatic stacking interactions e.g., F64 with F21, Y25,
F26; Y57 with Y65, F127; Y39 with W54 and W41
with F99.
Comparisons between the 43 ArdB and KlcA protein
sequences showed that they have highly conserved
a-helices and b-strands, while loops vary in length and
amino acid composition. Figure 10 shows a subset of the
sequences comprised of the proteins listed in Table 1 and
the archetypal KlcA from plasmid RK2 (20) and
archetypal ArdB from pKM101 (11). Mapping sequence
conservation (Supplementary Figure S5) onto the surface
of KlcA136 shows only three well-conserved patches,
comprising ﬁrstly H81 and D142, secondly L87, S88
and E133 and lastly E35, Y49, G51, A52 and W54,
Figure 11. Only the ﬁrst of these three patches projects
out from the surface, the others are on concave regions
of the surface.
Discussion
In this study, we have solved the atomic resolution struc-
ture of KlcA136, an anti-restriction protein belonging to
the ArdB family and showed its anti-restriction function
against Type I RM systems. We have also demonstrated
the same anti-restriction function for ﬁve other examples
of the ArdB/KlcA family from a range of organisms.
A particularly striking result is the absence of any inhi-
bition of a Type I RM enzyme in vitro. The EcoKI RM
enzyme was able to bind and cleave unmodiﬁed DNA in
the presence of either ArdB or KlcA proteins in contrast
to the result in vivo in which the enzyme failed to operate
against invading phage DNA in the presence of these
anti-restriction proteins. Thus the ArdB/KlcA proteins
must operate in a diﬀerent manner to the DNA mimics.
Several protein-based anti-restriction strategies aimed at
negating the activity of Type I RM systems have been
identiﬁed in addition to DNA mimicry (2), namely, hydro-
lysis of the essential S-adenosyl-L-methionine cofactor
(77), proteolysis of the HsdR subunit required for DNA
cleavage (30,32,71), enhancement of the Mtase activity via
the action of the lambda ral gene to allow protection of
unmethylated DNA targets (78) and interference with the
subunit assembly process forming the complete RM
enzyme (26). Our data and that of Belogurov et al. (11),
who demonstrated that ardB did not stimulate DNA mod-
iﬁcation by the EcoKI Type I RM system using a ral-like
mechanism, show that these mechanisms are not applica-
ble to the ArdB/KlcA proteins. Thus the mechanism of
anti-restriction by ArdB and KlcA remains unclear at
present. However, the variable quaternary structure
observed using size exclusion chromatography may
suggest a role for large scale conformational changes in
both tertiary and quaternary structure in ArdB and KlcA
as being involved in anti-restriction.
The structure of KlcA136 is the ﬁrst ArdB/KlcA struc-
ture reported and adopts a novel fold. Although three
distinct regions of charge are apparent from the
electrostatic surface representation, only a handful of
charged residues are conserved among the 43
non-redundant related sequences of the ArdB/KlcA
group. Other anti-restriction proteins, such as ocr from
Figure 9. Lipophilic surface representation of the KlcA136 protein. Two views, rotated by 180
 about the y-axis, of a MOLCAD-generated lipophilic
surface rendition of the protein. Regions of high lipophilicity or hydrophobicity are coloured brown and regions of high hydrophilicity are coloured
blue.
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Figure 10. A PROMALS3D sequence alignment of KlcA and ArdB proteins. KlcA_RK2 and ArdB_pKM101 are the archetypal sequences for these
two proteins (11,20). Yellow shading represents beta strands, red shading represents alpha helices and purple shading represents the 310 helix. The
grey shading highlights the anti-restriction motif LLREYVNTL in ArdB from pKM101 (7,26). Consensus amino acid symbols are: conserved amino
acids are in bold and uppercase letters; aliphatic (I, V, L): l; aromatic (Y, H, W, F): @; hydrophobic (W, F, Y, M, L, I, V, A, C, T, H): h; alcohol
(S, T): o; polar residues (D, E, H, K, N, Q, R, S, T): p; tiny (A, G, C, S): t; small (A, G, C, S, V, N, D, T, P): s; bulky residues (E, F, I, K, L, M, Q,
R, W, Y): b; positively charged (K, R, H): +; negatively charged (D, E): ; charged (D, E, K, R, H): c.
Figure 11. Sequence conservation mapped onto KlcA136 protein surface. Conservation surface representation based upon the PROMALS3D
multiple sequence alignment of ArdB and KlcA sequences (Supplementary Figure S5) where largely and completely conserved residues are shown
in lavender/plum/violet colour mapped onto the surface and variable residue positions coloured cyan.
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phage T7 (9) and ArdA from the conjugative transposon
Tn916 (8), have been shown to comprise elongated struc-
tures that bind to DNA binding site of the Mtase core of
the Type I RM enzyme, thereby rendering the enzyme
incapable of recognizing its DNA target both in vivo and
in vitro. The structure of KlcA136 on the other hand,
appears to be a rigid globular molecule of novel fold
and does not mimic double-stranded DNA.
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